Literature DB >> 17119797

[Reibergram for C3c intrathecal synthesis evaluation].

Alberto Juan Dorta-Contreras1, Elena Noris-García, Bárbara Padilla-Docal, Alexis Rodríguez-Rey, Raisa Bu-Coifiu-Fanego, María Esther Magraner-Tarrau, Mauricio Martí-Brenes.   

Abstract

INTRODUCTION: Reiber's quotient diagram or reibergram has a growing apply for characterize the intratecal synthesis of proteins. Firstly reibergrama was used for the major classes of immunoglobulins but later it was used to evaluate other proteins based on the theory about molecular flux/cerebrospinal fluid (CSF) flow rate.
METHOD: C3c is a degradation product of complement factor C3 with 145 KDa and approaches to IgG molecular characteristics according with Fick's diffusion laws. It was assumed IgG constants and graphic for IgG constants and graphic to evaluate the intrathecal synthesis of C3c. Twenty-seven patients and 27 controls were studied. Serum and CSF C3c and albumin were quantified by immunodiffusion.
RESULTS: The patients with the C3c proposed reibergram were evaluated. It has been proved its validity under several CSF blood barrier conditions.
CONCLUSION: Reibergram for C3c can be used for the evaluation of the intrathecal synthesis of this protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119797     DOI: 10.1590/s0004-282x2006000400010

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

Review 1.  Intrathecal activation as a typical immune response within the central nervous system in angiostrongyliasis.

Authors:  Barbara Padilla-Docal; Ivonne Iglesias-González; Raisa Bu-Coifiu-Fanego; Carmen Aleida Socarrás-Hernández; Alberto Juan Dorta-Contreras
Journal:  Am J Trop Med Hyg       Date:  2013-02       Impact factor: 2.345

2.  CSF/serum quotient graphs for the evaluation of intrathecal C4 synthesis.

Authors:  Barbara Padilla-Docal; Alberto J Dorta-Contreras; Raisa Bu-Coifiu-Fanego; Alexis Rodriguez Rey
Journal:  Cerebrospinal Fluid Res       Date:  2009-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.